Heron Therapeutics, Inc.
Heron Therapeutics, Inc. scores highest on Earnings (60) and lowest on Torque (1). Its PosiPenta is 25.16 out of 100, weaker than most similar companies.
On the Penta Grid this week, Heron Therapeutics, Inc. is Grid #808 of 837 in the Healthcare sector in United States, and Grid #3,811 of 4,000 in United States.
Compared with similar companies in the Healthcare sector in United States.
The five pillars
Similar companies
| Company | PosiPenta | P | E | N | T | A |
|---|---|---|---|---|---|---|
| Heron Therapeutics, Inc. | 25.16 | 7 | 60 | 28 | 1 | 30 |
| Gain Therapeutics, Inc. | 31.51 | 14 | 38 | 20 | 35 | 51 |
| Boundless Bio, Inc. | 51.27 | 42 | 45 | 78 | 35 | 57 |
| MindWalk Holdings Corp. | 38.80 | 6 | 69 | 42 | 27 | 51 |
| RenovoRx, Inc. | 41.36 | 12 | 65 | 45 | 42 | 43 |
| Gossamer Bio, Inc. | 32.36 | 0 | 34 | 4 | 97 | 27 |
Similar-sized companies in the same sector, this week. P Price · E Earnings · N Nitro · T Torque · A Anchor.
Details
PPrice
| P/E ratio | -2.01 |
| P/B ratio | 9.92 |
EEarnings
| Trailing EPS | ₹-17.05 |
| Forward EPS | ₹-10.42 |
NNitro
| Price | 34.19 |
| 52-week high | 149.65 |
| 52-week low | 24.63 |
| Fall from 52-week high | 77.2% |
TTorque
| Return on equity (ROE) | — |
| Debt-to-equity | 21.48 |
AAnchor
| Beta (price swings) | 1.62 |
| Market cap | ₹649 Cr |
| Insider holding | 0.98% |
| Dividend yield | 0.00% |
Figures as used for the week of 17 Oct 2026; today's figures on the company page may differ slightly.
Questions
What is Heron Therapeutics, Inc.'s PosiPenta score?
Heron Therapeutics, Inc.'s PosiPenta is 25.16 out of 100 for the week of 17 Oct 2026, based on 5 of 5 pillars.
Where does Heron Therapeutics, Inc. stand on the Penta Grid?
On the Penta Grid this week, Heron Therapeutics, Inc. is Grid #808 of 837 in the Healthcare sector in United States, and Grid #3,811 of 4,000 in United States.
Which PosiPenta pillar is strongest for Heron Therapeutics, Inc.?
Earnings (growth), with a score of 60 out of 100: better than most similar companies.
Which PosiPenta pillar is weakest for Heron Therapeutics, Inc.?
Torque (durability), with a score of 1 out of 100: much weaker than most similar companies.
Has Heron Therapeutics, Inc.'s PosiPenta changed since last week?
Yes, it rose 3.25 points, from 21.91 to 25.16.
PositoAI is for research and education only and is not investment advice.